Selskabets formål er at (i) besidde aktier og finansielle instrumenter og (ii) at drive anden virksomhed, der efter direktionens skøn er direkte eller indirekte forbundet hermed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 1.1 mia. | 21.9 mio. | 6 mia. | 3 mia. | 529 | |
CVR: 43531026
Secondary names: FeMD HoldCo ApS, FMD HoldCo ApS
Previous names: Moon HoldCo ApS
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
The financial health of Ferrosan Medical Devices HoldCo ApS appears solid, with a notable increase in revenue from 893.37 million DKK in 2023 to 1.08 billion DKK in 2025, indicating a strong growth trajectory. However, profit has fluctuated, peaking at 101.25 million DKK in 2024 before dropping to 21.91 million DKK in 2025, raising concerns about profitability margins. The company's equity position is robust, growing from 2.85 billion DKK in 2023 to nearly 3 billion DKK in 2025, suggesting a strong capital base. Overall, while revenue growth is promising, the volatility in profit margins may warrant closer scrutiny as the company navigates its position within the non-financial holding sector.
AI-generated summary
Companies in the same industry and area
CVR 32886795
CVR 43479342
CVR 39943646
CVR 31284007
CVR 30831276
companydata.dk